Congratulations to TOM Medications, one of our 2022 Innovation Booster Digital Health Nation alumni, for completing another financing round of 1.3 million Swiss francs.
Launched in June 2020, TOM Medications has already achieved numerous successes. Around 30 million interactions have already taken place via the app, and the adherence rate of TOM app users is 83 percent – significantly higher than the average of around 50 percent achieved by chronically ill patients.
The recent financing round showed that investors believe the virtual medicine cabinet has even more potential: At over 1.3 million Swiss francs, it was significantly oversubscribed by more than 120 percent. “The majority of previous investors were immediately willing to continue investing in 2022 because of the measurable successes,” said TOM founder and CEO Sven Beichler. If you want to learn more about TOM Medications you can also read the original article on Moneycab.